BioSpace News Archive

Business

ANTABIO Announces Key Executive Appointments

Antabio is pleased to announce the addition of four highly successful and accomplished biotech executives to the management team.

January 5, 2018
·
2 min read
Business

miRagen Therapeutics Expands Board of Directors With Appointment of Arlene Morris

Her appointment increases miRagen’s Board from seven directors to eight directors.

January 5, 2018
·
6 min read
Bio-Thera Solutions to Present at the Biotech Showcase 2018 Conference on January 10, 2018

Bio-Thera Solutions today announced that Bert Thomas, PhD, MBA, Bio-Thera’s Senior VP of Business Development, will present a corporate overview at Biotech Showcase 2018 on January 10th, 2018 at 11:00 AM Pacific Time.

January 5, 2018
·
1 min read
Biotech Beach

SignalRx Announces in Silico Design and Discovery of the First-in-Class HDAC6-BRD-PI3K Epigenetic Kinase Inhibitor SRX3225

SignalRx’s proprietary CRIMP technology platform led to the in silico design and identification of SRX3225 within its triple inhibitor program.

January 5, 2018
·
3 min read
Business

Lundbeck Enters Research Partnership on Novel Treatment of Schizophrenia

New partnership with Vanderbilt University sees Lundbeck acquire an exclusive license to a research program aimed at a novel approach to treating schizophrenia.

January 5, 2018
·
3 min read
Genetown

Zafgen Reports Strong Clinical Progress and Updates Outlook for 2018

The company will be returning to rare disorders with ZGN-1258.

January 5, 2018
·
8 min read
Business

IBA Signs Contract for Additional Treatment Capacity at Latin America’s First Proton Therapy Center In Argentina

IBA expects to receive a down payment for this new contract in the coming weeks.

January 5, 2018
·
3 min read
Drug Development

BriaCell Provides Clinical Update on its Lead Immunotherapy Drug in Advanced Breast Cancer

BriaCell is providing a clinical update regarding its ongoing clinical trials of Bria-IMT.

January 5, 2018
·
7 min read
Pharm Country

New Jersey’s Leading Pharma, LLC Scores $40M

The transaction was led by Signet Healthcare Partners in addition to Crestline Investors with other investors comprised of Cane Investment Partners and existing Leading Pharma members.

January 5, 2018
·
4 min read
Genetown

PerkinElmer to Hold Earnings Call on Thursday, January 25, 2018

The Company will also host a conference call the same day at 5:00 p.m. ET to discuss these results. Robert Friel, chairman and chief executive officer, and Andy Wilson, senior vice president and chief financial officer, will host the conference call.

January 5, 2018
·
1 min read